Evidence map›Paper›PMID 35406133›Full record

ArticleNutrients2022

Effect of a Fixed Combination of Curcumin, Artemisia, Bromelain, and Black Pepper Oral Administration on Optical Coherence Tomography Angiography Indices in Patients with Diabetic Macular Edema.

Flavia Chiosi, Michele Rinaldi, Giuseppe Campagna, Gianluigi Manzi, Vincenzo De Angelis, Francesco Calabrò, Luca D'Andrea, Fausto Tranfa, Ciro Costagliola

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Flavia ChiosiDepartment of Ophthalmology, Monaldi Hospital, Azienda Ospedaliera dei Colli Via Leonardo Bianchi, 8013 Napoli, Italy.ORCID 0000-0002-1728-6098
Michele RinaldiDepartment of Ophthalmology, University of Campania "Luigi Vanvitelli", 80100 Napoli, Italy.
Giuseppe CampagnaDepartment of Medical-Surgical Sciences and Translational Medicine, University of Rome "La Sapienza", 00161 Roma, Italy.ORCID 0000-0002-1884-9171
Gianluigi ManziDepartment of Ophthalmology, Monaldi Hospital, Azienda Ospedaliera dei Colli Via Leonardo Bianchi, 8013 Napoli, Italy.
Vincenzo De AngelisEye Clinic, Azienda Ospedaliera A. Cardarelli, 80131 Naples, Italy.
Francesco CalabròEye Clinic, Azienda Ospedaliera A. Cardarelli, 80131 Naples, Italy.
Luca D'AndreaEye Clinic, Department of Neuroscience, Reproductive Sciences and Dentistry, University of Napoli "Federico II", 80138 Napoli, Italy.
Fausto TranfaEye Clinic, Department of Neuroscience, Reproductive Sciences and Dentistry, University of Napoli "Federico II", 80138 Napoli, Italy.
Ciro CostagliolaEye Clinic, Department of Neuroscience, Reproductive Sciences and Dentistry, University of Napoli "Federico II", 80138 Napoli, Italy.ORCID 0000-0001-8477-6188
University of Naples Federico II · ITOspedale Antonio Cardarelli · ITOspedale Monaldi · ITSapienza University of Rome · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To investigate the effects of a fixed combination of Curcumin (200 mg), Artemisia (80 mg), Bromelain (80 mg), and Black pepper (2 mg) on vascular parameters in mild to moderate diabetic macular edema (DME). Design: Prospective, case-control study. Methods: Fifty-six patients affected by diabetes mellitus type II were enrolled in the study. Twenty-eight patients with DME received 2 tablets/day, before meals of a dietary complementary supplement containing in fixed combination Curcumin (200 mg), Artemisia (80 mg), Bromelain (80 mg), and Black pepper (2 mg) (Intravit®, OFFHEALTH Spa, Firenze, Italy) for 6 months. Twenty-eight age-matched subjects affected by diabetes mellitus type II were given placebo and served as control group. Patients underwent best correct visual acuity (BCVA), swept optical coherence tomography (OCT), and OCT-Angiography (OCTA). OCTA images of the superficial capillary plexus (SCP) and deep capillary plexus (DCP) were obtained for each eye. By the end of the follow-up patients were defined responder to the therapy when a decrease of more than 30 μm was registered in central retinal thickness (CRT) measurement, while a poor responder was determined by the absence of reduction or an increase in central retinal thickness at 6 months. We assessed the foveal avascular zone (FAZ) area, vessel density and quantified the number of microaneurysms in each layer. Results: A significant improvement of BCVA and CRT reduction was recorded at 6 months follow-up in the dietary complementary supplementation group compared to control (respectively p = 0.028 and p = 0.0003). VD of the total capillary plexus, microaneurysms count, glycaemia and HbA1c did not vary over the follow-up period between groups. Within the Intravit® group, poor responders tended to show a larger FAZ area, more microaneurysms, and a lower VD in the DCP compared to the good responders group (p < 0.0001). Conclusions: A fixed combination of Curcumin, Artemisia, Bromelain, and Black pepper oral administration may have a positive impact on central retinal thickness, visual acuity, and VD of the DCP in compensated type 2 diabetic patients with mild DME.

Indexed as

ArtemisiaCurcuminDiabetes MellitusDiabetic RetinopathyMacular EdemaMicroaneurysmPiper nigrumAdministration, OralBromelainsCase-Control StudiesFluorescein AngiographyHumansProspective StudiesRetinal VesselsRetrospective StudiesTomography, Optical CoherenceBromelainsCurcuminartemisiablack pepperbromelaincurcumindiabetic macular edemadiabetic retinopathyOCTAvascular flow density

Identifiers

PMID35406133
PMCPMC9002511
OpenAlexW4223629907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.